All AbMole products are for research use only, cannot be used for human consumption.
Suplatast tosylate is a Th2 cytokine inhibitor which is used as an anti-allergic drug. Suplatast tosylate is a novel anti-allergic agent that suppresses several processes, including the synthesis of IL-4 and IL-5 in both human and murine Th2 (-like) cells; IgE synthesis in both mice and humans, with no direct effect on B cells; local eosinophilia regulated by Th2 cells in mice; and infiltration of both eosinophils and CD41 T cells into the airways, with consequent airway hyperresponsiveness after allergen inhalation in sensitized guinea pigs.
| Cell Experiment | |
|---|---|
| Cell lines | Dendritic cells (DCs) and CD4+ T cells |
| Preparation method | Using magnetic cell separation system micro-beads and columns, allogeneic responder CD4+ T cells which are obtained from healthy subjects are purified from PBMCs by negative depletion of CD14+, CD16+, CD19+, CD56+, and CD8+ cells . After 7 days of culture with GM-CSF and IL-4, iDCs which are differentiated from monocytes in the presence or absence of Suplatast tosilate (10 and 100 mg/ mL), are co-cultured with purified 1×10 5 allogeneic CD41 T cells at varying ratios of iDCs in 96-well round bottomed culture plates for 5 days. Pulsing cells with 1 μCi of 3H-methylthymidine for the last 8 hours of the culture period. Counting incorporated radioactivity with a liquid scintillation counter, and expressing proliferative responses as the mean 3 H-methylthymidine incorporation (counts per minutes) of triplicate wells_SEM. Also, assessing proliferation of DCs alone or CD4+ T cells alone. |
| Concentrations | 10 or 100 μg/mL |
| Incubation time | 5 days |
| Animal Experiment | |
|---|---|
| Animal models | BALB/c mice sensitized to ovalbumin |
| Formulation | Dissolved in sterile saline. |
| Dosages | 100 mg/kg/100 μL |
| Administration | Orally once a day for 21 days |
| Molecular Weight | 499.64 |
| Formula | C23H33NO7S2 |
| CAS Number | 94055-76-2 |
| Solubility (25°C) | DMSO 90 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related IL Receptor/Related Products |
|---|
| IL-17A modulator-2
IL-17A modulator-2 is a IL-17A modulator. IL-17A modulator-2 inhibits the biological action of IL-17A with a pIC50 of 8.3. IL-17A modulator-2 can be used for the research of diseases associated with modulation of IL-17A activity. |
| IL-15-IN-1
IL-15-IN-1 is a potent and selective Interleukin 15 (IL-15) inhibitor, inhibiting the proliferation of IL-15-dependent cells with an IC50 of 0.8 μM. |
| IL-17 modulator 3
IL-17 modulator 3 is an IL-17 modulator. |
| IL-17 modulator 4
IL-17 modulator 4 is a proagent of IL-17 modulator 1. IL-17 modulator 1 is an orally active, highly efficacious IL-17 modulator. IL-17 modulator 4 is promising for the research of IL-17A mediated diseases, including inflammation, autoimmune diseases, infectious diseases, cancer, and precancerous syndrome. |
| IL-17A modulator-3
IL-17A modulator-3 is a IL-17A modulator. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
